Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-03 Sale |
2024-05-07 5:13 pm |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
257 | $3.106 | $798 | 317,323 (Direct) |
View |
| 2024-05-03 Sale |
2024-05-07 5:13 pm |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
913 | $3.106 | $2,836 | 137,236 (Direct) |
View |
| 2024-04-22 Sale |
2024-04-24 4:17 pm |
Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks |
5,000 | $3.0979 | $15,490 | 390,092 (Indirect Direct) |
View |
| 2024-03-06 Sale |
2024-03-08 6:29 pm |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
53,515 | $5.0394 | $269,682 | 474,290 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-21 4:10 pm |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
485 | $4.8624 | $2,358 | 336,319 (Direct) |
View |
| 2024-02-05 Sale |
2024-02-07 5:21 pm |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
1,200 | $4.1409 | $4,969 | 303,580 (Direct) |
View |
| 2024-02-05 Sale |
2024-02-07 5:21 pm |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
3,819 | $4.1428 | $15,821 | 114,149 (Direct) |
View |
| 2023-03-21 Sale |
2023-03-23 7:31 pm |
Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer |
144,911 | $3.7256 | $539,879 | 778,997 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-07 Option Award |
2024-03-18 5:48 pm |
N/A 2034-03-07 |
Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO |
121,975 | $0 | 1,575,254 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 7:38 pm |
N/A 2034-03-07 |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
95,000 | $0 | 398,580 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 7:36 pm |
N/A 2034-03-07 |
Century Therapeutics Inc. | IPSC | Russotti Gregory See Remarks |
170,000 | $0 | 541,092 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 7:35 pm |
N/A 2034-03-07 |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
170,000 | $0 | 284,149 (Direct) |
View |
| 2024-03-07 Option Award |
2024-03-11 7:34 pm |
N/A 2034-03-07 |
Century Therapeutics Inc. | IPSC | Levitsky Hyam President of R&D |
170,000 | $0 | 706,544 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 6:29 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
53,515 | $1.03 | 474,290 (Direct) |
View |
| 2024-03-06 Exercise |
2024-03-08 6:29 pm |
N/A 2029-07-17 |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
53,515 | $0 | 474,290 (Direct) |
View |
| 2024-02-16 Exercise |
2024-02-21 4:10 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
485 | $1.03 | 336,319 (Direct) |
View |
| 2024-02-16 Exercise |
2024-02-21 4:10 pm |
N/A 2029-07-17 |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
485 | $0 | 336,319 (Direct) |
View |
| 2023-12-04 Option Award |
2023-12-06 4:07 pm |
N/A 2033-12-04 |
Century Therapeutics Inc. | IPSC | Pfeiffenberger Brent President and CEO |
2,026,970 | $0 | 2,026,970 (Direct) |
View |
| 2023-11-01 Tax Withholding |
2023-11-03 4:04 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
16,611 | $1.49 | 304,780 (Direct) |
View |
| 2023-11-01 Tax Withholding |
2023-11-03 4:04 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Diem Michael Craig Chief Financial Officer |
20,763 | $1.49 | 253,533 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:23 pm |
N/A 2024-06-27 |
Century Therapeutics Inc. | IPSC | Carlo Rizzuto Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:22 pm |
N/A 2024-06-27 |
Century Therapeutics Inc. | IPSC | Riva Alessandro Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:21 pm |
N/A 2024-06-27 |
Century Therapeutics Inc. | IPSC | JIMENEZ JOSEPH Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:20 pm |
N/A 2024-06-27 |
Century Therapeutics Inc. | IPSC | BUTITTA CYNTHIA M Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:20 pm |
N/A 2024-06-27 |
Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:19 pm |
N/A 2024-06-27 |
Century Therapeutics Inc. | IPSC | Quimi Daphne Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-06-27 Option Award |
2023-06-29 4:18 pm |
N/A 2024-06-27 |
Century Therapeutics Inc. | IPSC | Walbert Timothy P Director |
44,000 | $0 | 44,000 (Direct) |
View |
| 2023-05-15 Option Award |
2023-05-17 4:33 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Carr Douglas SVP Finance & Operations |
120,846 | $0 | 321,391 (Direct) |
View |
| 2023-05-15 Option Award |
2023-05-17 4:32 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Diem Michael Craig Chief Financial Officer |
151,058 | $0 | 274,296 (Direct) |
View |
| 2023-04-12 Option Award |
2023-04-14 7:56 pm |
N/A 2033-04-12 |
Century Therapeutics Inc. | IPSC | Levitsky Hyam President of R&D |
131,250 | $0 | 131,250 (Direct) |
View |
Ownership |
2023-04-14 7:55 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Levitsky Hyam President of R&D |
0 | $0 | 570,660 (Indirect) |
View |
| 2023-04-11 Option Award |
2023-04-13 5:29 pm |
N/A 2033-04-11 |
Century Therapeutics Inc. | IPSC | Russotti Gregory Chief Technology Officer |
318,750 | $0 | 318,750 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 4:27 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer |
7,452 | $1.03 | 256,535 (Direct) |
View |
| 2023-04-03 Exercise |
2023-04-05 4:27 pm |
N/A 2029-07-17 |
Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer |
7,452 | $0 | 256,535 (Direct) |
View |
| 2023-03-21 Exercise |
2023-03-23 7:31 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer |
350,244 | $1.03 | 778,997 (Direct) |
View |
| 2023-03-21 Exercise |
2023-03-23 7:31 pm |
N/A 2029-07-17 |
Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer |
350,244 | $0 | 778,997 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-06 6:52 pm |
N/A 2033-02-02 |
Century Therapeutics Inc. | IPSC | Flores Osvaldo Chief Executive Officer |
1,275,000 | $0 | 1,275,000 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-06 6:52 pm |
N/A 2033-02-02 |
Century Therapeutics Inc. | IPSC | Carr Douglas VP Finance & Operations |
97,500 | $0 | 290,545 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-06 6:51 pm |
N/A 2033-02-02 |
Century Therapeutics Inc. | IPSC | Russotti Gregory Chief Technology Officer |
350,000 | $0 | 350,000 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-06 6:50 pm |
N/A 2033-02-02 |
Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer |
284,375 | $0 | 306,250 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-06 6:49 pm |
N/A 2033-02-02 |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
284,375 | $0 | 380,468 (Direct) |
View |
| 2023-02-02 Option Award |
2023-02-06 6:49 pm |
N/A 2033-02-02 |
Century Therapeutics Inc. | IPSC | Diem Michael Craig Chief Business Officer |
284,375 | $0 | 385,738 (Direct) |
View |
| 2022-10-01 Option Award |
2022-10-03 4:08 pm |
N/A 2032-10-01 |
Century Therapeutics Inc. | IPSC | Quimi Daphne Director |
39,744 | $0 | 39,744 (Direct) |
View |
| 2022-10-01 Option Award |
2022-10-03 4:07 pm |
N/A 2032-10-01 |
Century Therapeutics Inc. | IPSC | Walbert Timothy P Director |
39,744 | $0 | 39,744 (Direct) |
View |